-
Je něco špatně v tomto záznamu ?
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023
D. Cibula, MR. Raspollini, F. Planchamp, C. Centeno, C. Chargari, A. Felix, D. Fischerová, D. Jahnn-Kuch, F. Joly, C. Kohler, S. Lax, D. Lorusso, U. Mahantshetty, P. Mathevet, R. Naik, RA. Nout, A. Oaknin, F. Peccatori, J. Persson, D. Querleu,...
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 2003-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2011-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 2003-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2003-01-01 do Před 1 rokem
- MeSH
- kvalita života MeSH
- lékařská onkologie MeSH
- lidé MeSH
- nádory děložního čípku * diagnóza terapie patologie MeSH
- těhotenství MeSH
- Check Tag
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines on all relevant issues of diagnosis and treatment in cervical cancer.To serve on the expert panel (27 experts across Europe) ESGO/ESTRO/ESP nominated practicing clinicians who are involved in managing patients with cervical cancer and have demonstrated leadership through their expertise in clinical care and research, national and international engagement, profile, and dedication to the topics addressed. To ensure the statements were evidence based, new data identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the international development group. Before publication, the guidelines were reviewed by 155 independent international practitioners in cancer care delivery and patient representatives.These updated guidelines are comprehensive and cover staging, management, follow-up, long-term survivorship, quality of life and palliative care. Management includes fertility sparing treatment, early and locally advanced cervical cancer, invasive cervical cancer diagnosed on a simple hysterectomy specimen, cervical cancer in pregnancy, rare tumors, recurrent and metastatic diseases. The management algorithms and the principles of radiotherapy and pathological evaluation are also defined.
Aarhus University Hospital Aarhus Denmark
Asklepios Clinic Altona Hamburg Germany
Asklepios Comprehensive Tumor Center Hamburg Germany
Catholic University of Sacred Heart Rome Italy
Clinical Research Unit Institut Bergonie Bordeaux France
Department of Internal Medicine Medical University of Graz Graz Austria
Department of Obstetrics and Gynecology Lund University Hosptial Lund Sweden
Department of Palliative Medicine University of Navarra Pamplona Spain
Department of Radiation Oncology Medical University of Vienna Wien Austria
European Institute of Oncology IRCCS Milan Italy
Fondazione Policlinico Universitario A Gemelli IRCCS Rome Italy
François Baclesse Centre de Lutte Contre le Cancer Caen France
General University Hospital Prague Prague Czech Republic
Gynecologic Oncology La Paz University Hospital Madrid Spain
Gynecologic Oncology Nairi Medical Center Yerevan Armenia
Homi Bhabha Cancer Hospital and Research Centre Visakhapatnam Andhra Pradesh India
Hospital Universitari Vall d'Hebron Barcelona Spain
Instituto Portugues de Oncologia de Lisboa Francisco Gentil EPE Lisboa Portugal
Johannes Kepler Universitat Linz Linz Austria
Medical Oncology Clinica Universidad de Navarra Pamplona Spain
Medical University of Graz Graz Austria
National Cancer Institute Kiev Ukraine
Northern Gynaecological Oncology Centre Gateshead UK
Radiotherapy Erasmus MC Cancer Centre Rotterdam The Netherlands
Service d'Oncologie Radiothérapie Hôpital Universitaire Pitié Salpêtrière Paris France
Skåne University Hospital Lund Lund Sweden
Universidade Nova de Lisboa Lisboa Portugal
University Hospital Careggi Firenze Italy
University Hospitals Strasbourg Strasbourg France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011183
- 003
- CZ-PrNML
- 005
- 20230801132843.0
- 007
- ta
- 008
- 230718s2023 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00428-023-03552-3 $2 doi
- 035 __
- $a (PubMed)37145263
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Cibula, David $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University, Prague, 121 08, Czech Republic. dc@davidcibula.cz $u General University Hospital in Prague, Prague, Czech Republic. dc@davidcibula.cz $1 https://orcid.org/0000000163879356 $7 jo20000074072
- 245 10
- $a ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023 / $c D. Cibula, MR. Raspollini, F. Planchamp, C. Centeno, C. Chargari, A. Felix, D. Fischerová, D. Jahnn-Kuch, F. Joly, C. Kohler, S. Lax, D. Lorusso, U. Mahantshetty, P. Mathevet, R. Naik, RA. Nout, A. Oaknin, F. Peccatori, J. Persson, D. Querleu, SR. Bernabé, MP. Schmid, A. Stepanyan, V. Svintsitskyi, K. Tamussino, I. Zapardiel, J. Lindegaard
- 520 9_
- $a In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines on all relevant issues of diagnosis and treatment in cervical cancer.To serve on the expert panel (27 experts across Europe) ESGO/ESTRO/ESP nominated practicing clinicians who are involved in managing patients with cervical cancer and have demonstrated leadership through their expertise in clinical care and research, national and international engagement, profile, and dedication to the topics addressed. To ensure the statements were evidence based, new data identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the international development group. Before publication, the guidelines were reviewed by 155 independent international practitioners in cancer care delivery and patient representatives.These updated guidelines are comprehensive and cover staging, management, follow-up, long-term survivorship, quality of life and palliative care. Management includes fertility sparing treatment, early and locally advanced cervical cancer, invasive cervical cancer diagnosed on a simple hysterectomy specimen, cervical cancer in pregnancy, rare tumors, recurrent and metastatic diseases. The management algorithms and the principles of radiotherapy and pathological evaluation are also defined.
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory děložního čípku $x diagnóza $x terapie $x patologie $7 D002583
- 650 _2
- $a kvalita života $7 D011788
- 650 _2
- $a lékařská onkologie $7 D008495
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Raspollini, Maria Rosaria $u University Hospital Careggi, Firenze, Italy
- 700 1_
- $a Planchamp, François $u Clinical Research Unit, Institut Bergonie, Bordeaux, France $1 https://orcid.org/0000000287090410
- 700 1_
- $a Centeno, Carlos $u Department of Palliative Medicine, University of Navarra, Pamplona, Spain
- 700 1_
- $a Chargari, Cyrus $u Service d'Oncologie Radiothérapie, Hôpital Universitaire Pitié Salpêtrière, Paris, France $1 https://orcid.org/0000000301193695
- 700 1_
- $a Felix, Ana $u Instituto Portugues de Oncologia de Lisboa Francisco Gentil EPE, Lisboa, Portugal $u Universidade Nova de Lisboa, Lisboa, Portugal
- 700 1_
- $a Fischerová, Daniela $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University, Prague, 121 08, Czech Republic $u General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000272243218 $7 xx0074804
- 700 1_
- $a Jahnn-Kuch, Daniela $u Department of Internal Medicine, Medical University of Graz, Graz, Austria
- 700 1_
- $a Joly, Florence $u François Baclesse Centre de Lutte Contre le Cancer, Caen, France
- 700 1_
- $a Kohler, Christhardt $u Asklepios Clinic Altona, Hamburg, Germany $u Asklepios Comprehensive Tumor Center, Hamburg, Germany
- 700 1_
- $a Lax, Sigurd $u Hospital Graz II, Graz, Austria $u Johannes Kepler Universitat Linz, Linz, Austria
- 700 1_
- $a Lorusso, Domenica $u Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy $u Catholic University of Sacred Heart, Rome, Italy
- 700 1_
- $a Mahantshetty, Umesh $u Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, Andhra Pradesh, India
- 700 1_
- $a Mathevet, Patrice $u CHUV, Lausanne, Switzerland
- 700 1_
- $a Naik, Raj $u Northern Gynaecological Oncology Centre, Gateshead, UK
- 700 1_
- $a Nout, Remi A $u Radiotherapy, Erasmus MC Cancer Centre, Rotterdam, The Netherlands $u University Medical Center, Rotterdam, The Netherlands
- 700 1_
- $a Oaknin, Ana $u Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain $u Hospital Universitari Vall d'Hebron, Barcelona, Spain $1 https://orcid.org/0000000235927194
- 700 1_
- $a Peccatori, Fedro $u European Institute of Oncology IRCCS, Milan, Italy
- 700 1_
- $a Persson, Jan $u Department of Obstetrics and Gynecology, Lund University Hosptial, Lund, Sweden $u Skåne University Hospital Lund, Lund, Sweden
- 700 1_
- $a Querleu, Denis $u Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy $u University Hospitals Strasbourg, Strasbourg, France $1 https://orcid.org/0000000239844812
- 700 1_
- $a Bernabé, Sandra Rubio $u Medical Oncology, Clinica Universidad de Navarra, Pamplona, Spain $1 https://orcid.org/0000000178575363
- 700 1_
- $a Schmid, Maximilian P $u Department of Radiation Oncology, Medical University of Vienna, Wien, Austria
- 700 1_
- $a Stepanyan, Artem $u Gynecologic Oncology, Nairi Medical Center, Yerevan, Armenia $1 https://orcid.org/0000000319610004
- 700 1_
- $a Svintsitskyi, Valentyn $u National Cancer Institute, Kiev, Ukraine
- 700 1_
- $a Tamussino, Karl $u Medical University of Graz, Graz, Austria
- 700 1_
- $a Zapardiel, Ignacio $u Gynecologic Oncology, La Paz University Hospital, Madrid, Spain $1 https://orcid.org/0000000291757767
- 700 1_
- $a Lindegaard, Jacob $u Aarhus University Hospital, Aarhus, Denmark
- 773 0_
- $w MED00004660 $t Virchows Archiv : an international journal of pathology $x 1432-2307 $g Roč. 482, č. 6 (2023), s. 935-966
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37145263 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132840 $b ABA008
- 999 __
- $a ok $b bmc $g 1963521 $s 1197448
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 482 $c 6 $d 935-966 $e 20230505 $i 1432-2307 $m Virchows Archiv $n Virchows Arch $x MED00004660
- LZP __
- $a Pubmed-20230718
